| Literature DB >> 32052013 |
Trynke Hoekstra1, Anna Galina Maria Rojer2, Natasja M van Schoor3, Andrea Britta Maier2,4, Mirjam Pijnappels2.
Abstract
BACKGROUND: Physical performance is an important factor for successful aging. This study aimed to identify distinct trajectories of multiple physical performance measures over 9 years in individuals aged 60-70 years and to evaluate their characteristics and the overlap between measures.Entities:
Keywords: Chair stand; Handgrip strength; Latent class growth models; Physical functional performance; Walking speed
Year: 2020 PMID: 32052013 PMCID: PMC7518554 DOI: 10.1093/gerona/glaa045
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.053
Figure 1.Identified trajectories of physical performance measures.
Characteristics for the Subgroups Classified in Distinct Trajectories of Gait Speed in Community-Dwelling Adults of 60–70 Years
| Males ( | Females ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Low, declining ( | Intermediate, stable ( | High, stable ( |
| Low, declining ( | Intermediate, stable ( | High, stable ( |
| |
| Gait speed, m/s | ||||||||
| Baseline | 0.51 ± 0.16 | 0.90 ± 0.18 | 1.18 ± 0.28 |
| 0.69 ± 0.17 | 0.89 ± 0.19 | 1.20 ± 0.19 |
|
| 3-y follow-up | 0.37 ± 0.07 | 0.77 ± 0.17 | 1.10 ± 0.23 |
| 0.56 ± 0.17 | 0.77 ± 0.16 | 1.15 ± 0.21 |
|
| 6-y follow-up | 0.28 ± 0.07 | 0.75 ± 0.19 | 1.05 ± 0.22 |
| 0.52 ± 0.16 | 0.79 ± 0.16 | 1.02 ± 0.21 |
|
| 9-y follow-up | 0.21 ± 0.04 | 0.71 ± 0.18 | 1.08 ± 0.17 |
| 0.43 ± 0.13 | 0.75 ± 0.15 | 0.94 ± 0.13 |
|
| Clinical variables at baseline | ||||||||
| Age, years | 68.3 ± 2.5 | 68.0 ± 1.6 | 67.7 ± 1.6 | .439 | 68.8 ± 1.8 | 67.7 ± 1.5 | 67.9 ± 1.9 |
|
| Number of medications | 4 (2–6) | 2 (1–3) | 2 (1–3) | .142 | 2.5 (1–4) | 2 (1–3) | 1 (1–3) | .327 |
| Multimorbiditya | 2 (33.3%) | 30 (22.7%) | 10 (21.3%) | .802 | 16 (33.3) | 29 (22.3) | 6 (22.2) | .302 |
| Males ( | Females ( | |||||||
| Low, declining ( | Intermediate, stable ( | High, stable ( |
| Low, declining ( | Intermediate, stable ( | High, stable ( |
| |
| Cognitive functioning, MMSE score (0–30) | 28 (26–29) | 28 (27–29) | 29 (27–29) | .328 | 28 (27–29) | 28 (27–29) | 28 (27–29) | .852 |
| Depressive symptoms present (>16 CES-D) | 0 (0%) | 6 (4.5%) | 1 (2.1%) | .666 | 8 (16.7%) | 16 (12.3%) | 1 (3.7%) | .258 |
| ≥1 fall within last 12 mo | 3 (50.0%) | 40 (30.3%) | 12 (25.5%) | .450 | 13 (27.1%) | 43 (33.1%) | 6 (22.2%) | .462 |
| Lifestyle variables at baseline | ||||||||
| Physical activity, LAPAQ score, minute/week | 758 ± 661 | 1,093 ± 753 | 1,017 ± 585 | .465 | 1,337 ± 714 | 1,477 ± 737 | 1,339 ± 582 | .409 |
| Males ( | Females ( | |||||||
| Low, declining ( | Intermediate, stable ( | High, stable ( |
| Low, declining ( | Intermediate, stable ( | High, stable ( |
| |
| Smoking behavior | ||||||||
| Never smoker | 0 (0%) | 13 (9.8%) | 7 (14.9%) | .379 | 24 (50.0%) | 63 (48.5%) | 13 (48.1%) | .517 |
| Former smoker | 4 (66.7%) | 87 (65.9%) | 34 (72.3%) | 12 (25.0%) | 43 (33.1%) | 11 (40.7%) | ||
| Current smoker | 2 (33.3%) | 32 (24.2%) | 6 (12.8%) | 12 (25.0%) | 24 (18.5%) | 3 (11.1%) | ||
| Glasses alcohol/week | 0.5 (0–15) | 6 (3–21) | 6 (3–21) | 0.166 | 2 (0.5–7) | 1 (0–6) | 3 (1–7) | .160 |
| Physical performance-related variables at baseline | ||||||||
| Unable to perform tandem stand for 10 s | 4 (66.7%) | 14 (10.6%) | 9 (19.1%) |
| 21 (43.8%) | 24 (18.5%) | 7 (25.9%) |
|
| Chair stands, s | 20.7 ± 6.5 | 12.3 ± 3.1 | 10.0 ± 2.2 |
| 14.1 ± 4.8 | 11.7 ± 2.9 | 10.8 ± 1.9 |
|
| Handgrip strength, kg | 32.5 ± 13.1 | 42.0 ± 7.3 | 42.8 ± 6.1 |
| 23.6 ± 5.0 | 25.6 ± 4.6 | 25.8 ± 4.5 |
|
Note: CES-D = Center for Epidemiologic Studies-Depression; LAPAQ = LASA physical activity questionnaire; MMSE = Mini-Mental State Examination.
aMultimorbidity defined as ≥2 of the following chronic diseases: cardiovascular disease, peripheral artery disease, diabetes mellitus, cerebrovascular accident or stroke, chronic obstructive pulmonary disease, arthritis, and cancer. Data are presented as mean ± SD, n (%), or median (IQR).
*One-way ANOVA for normally distributed variables, Kruskal–Wallis ANOVA for non-normally distributed variables, Chi-square for frequencies.
Characteristics for the Subgroups Classified in Distinct Trajectories of Chair Stand Performance in Community-Dwelling Adults of 60–70 Years
| Males ( | Females ( | |||||
|---|---|---|---|---|---|---|
| Declining ( | Stable ( |
| Declining ( | Stable ( |
| |
| Chair stand, s | ||||||
| Baseline | 17.7 ± 5.0 | 11.4 ± 2.8 |
| 15.3 ± 3.3 | 10.9 ± 1.7 |
|
| 3-y follow-up | 21.6 ± 7.1 | 11.7 ± 2.7 |
| 18.1 ± 7.1 | 12.5 ± 2.6 |
|
| 6-y follow-up | 23.9 ± 6.5 | 11.6 ± 2.6 | .077 | 17.1 ± 2.7 | 11.9 ± 2.6 |
|
| 9-y follow-up | 20.8 ± 3.9 | 13.0 ± 3.1 |
| 20.1 ± 4.1 | 12.8 ± 2.5 |
|
| Clinical variables at baseline | ||||||
| Age, years | 69.2 ± 1.7 | 67.9 ± 1.6 |
| 68.3 ± 1.7 | 67.9 ± 1.7 | .156 |
| Number of medications | 3 (2–5) | 2 (1–3) | .071 | 2.5 (1–5) | 2 (1–3) | .029 |
| Multimorbiditya | 2 (20.0%) | 36 (21.4%) | .915 | 13 (34.2) | 29 (19.4) | .049 |
| Cognitive functioning, MMSE score (0–30) | 28 (26–29) | 28 (27–29) | .362 | 29 (28–30) | 28 (27–29) | .003 |
| Males ( | Females ( | |||||
| Declining ( | Stable ( |
| Declining ( | Stable ( |
| |
| Depressive symptoms present (>16 CES-D) | 2 (20.0%) | 5 (3.0%) | .051 | 8 (21.1%) | 12 (8.0%) |
|
| ≥1 fall within last 12 mo | 4 (40.0%) | 47 (28.0%) | .475 | 14 (36.8%) | 41 (27.3%) | .318 |
| Lifestyle variables at baseline | ||||||
| Physical activity, LAPAQ score, minute/week | 878 ± 520 | 1,087 ± 722 | .395 | 1,317 ± 570 | 1,478 ± 753 | .222 |
| Smoking behavior | ||||||
| Never smoker | 1 (10.0%) | 19 (11.3%) | 0.215 | 20 (52.6%) | 71 (47.3%) | .789 |
| Former smoker | 9 (90.0%) | 111 (66.1%) | 11 (28.9%) | 52 (34.7%) | ||
| Current smoker | 0 (0%) | 38 (22.6%) | 7 (18.4%) | 27 (18.0%) | ||
| Glasses alcohol/week | 10 (2–23) | 6 (3–21) | 0.462 | 2 (0.5–6) | 2 (0.5–6) | .972 |
| Males ( | Females ( | |||||
| Declining ( | Stable ( |
| Declining ( | Stable ( |
| |
| Physical performance-related variables at baseline | ||||||
| Unable to perform tandem stand for 10 s | 0 (0%) | 24 (14.3%) | .362 | 8 (21.1%) | 37 (24.7%) | .677 |
| Gait speed, m/s | 0.81 ± 0.17 | 0.98 ± 0.25 |
| 0.79 ± 0.20 | 0.92 ± 0.23 |
|
| Handgrip strength, kg | 37.3 ± 4.2 | 42.6 ± 7.1 |
| 24.6 ± 5.0 | 25.6 ± 4.7 | .288 |
Note: CES-D = Center for Epidemiologic Studies-Depression; LAPAQ = LASA physical activity questionnaire; MMSE = Mini-Mental State Examination.
aMultimorbidity defined as ≥2 of the following chronic diseases: cardiovascular disease, peripheral artery disease, diabetes mellitus, cerebrovascular accident or stroke, chronic obstructive pulmonary disease, arthritis, and cancer.
Data are presented as mean ± SD, n (%), or median (IQR).
*Independent samples t-test for normally distributed variables, Mann–Whitney U-test for non-normally distributed variables, Fisher’s Exact Test for frequencies.
Characteristics for the Subgroups Classified in Distinct Trajectories of Decline in Handgrip Strength in Community-Dwelling Adults of 60–70 Years
| Males ( | Females ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Low, declining ( | Intermediate, declining ( | High, declining ( |
| Low, declining ( | Intermediate, declining ( | High, declining ( |
| |
| Handgrip strength, kg | ||||||||
| Baseline | 29.8 ± 5.8 | 40.2 ± 4.5 | 48.8 ± 5.7 |
| 16.8 ± 3.4 | 22.9 ± 2.5 | 29.9 ± 2.8 |
|
| 3-y follow-up | 23.3 ± 5.4 | 35.3 ± 5.6 | 46.3 ± 5.5 |
| 9.9 ± 6.4 | 21.5 ± 5.0 | 27.4 ± 4.4 |
|
| 6-y follow-up | 21.1 ± 5.5 | 35.8 ± 5.4 | 46.3 ± 5.6 |
| 11.5 ± 7.2 | 21.3 ± 4.7 | 27.1 ± 5.2 |
|
| 9-y follow-up | 25.3 ± 4.7 | 35.0 ± 4.6 | 45.0 ± 4.4 |
| 15.5 ± 0.6 | 20.2 ± 3.1 | 26.8 ± 3.1 |
|
| Clinical variables at baseline | ||||||||
| Age, years | 68.6 ± 1.9 | 68.0 ± 1.6 | 67.4 ± 1.6 |
| 69.1 ± 1.8 | 68.1 ± 1.8 | 67.6 ± 1.5 |
|
| Number of medications | 2 (2–4) | 2 (1–4) | 2 (1–2) | .034 | 3 (1–5.8) | 2 (1–4) | 1 (1–3) | .058 |
| Multimorbiditya | 2 (11.8%) | 31 (27.9%) | 8 (14.5%) | .082 | 3 (30.0%) | 36 (30.5%) | 12 (16.0%) | .072 |
| Males ( | Females ( | |||||||
| Low, declining ( | Intermediate, declining ( | High, declining ( |
| Low, declining ( | Intermediate, declining ( | High, declining ( |
| |
| Cognitive functioning, MMSE score (0–30) | 28 (25–29) | 28 (27–29) | 29 (27–29) | .218 | 28 (27–29) | 28 (27–29) | 29 (27–29) | .383 |
| Depressive symptoms present (>16 CES-D) | 3 (17.6%) | 3 (2.7%) | 1 (1.8%) |
| 2 (20.0%) | 17 (14.4%) | 5 (6.7%) | .181 |
| ≥1 fall within last 12 mo | 6 (35.3%) | 33 (29.7%) | 16 (29.1%) | .882 | 3 (30.0%) | 36 (30.5%) | 23 (30.7%) | .999 |
|
| ||||||||
| Physical activity, LAPAQ score, minute/week | 1,363 ± 976 | 1,035 ± 740 | 1,034 ± 549 | .216 | 1,508 ± 816 | 1,371 ± 652 | 1,499 ± 786 | .449 |
| Males ( | Females ( | |||||||
| Low, declining ( | Intermediate, declining ( | High, declining ( |
| Low, declining ( | Intermediate, declining ( | High, declining ( |
| |
| Smoking behavior | ||||||||
| Never smoker | 4 (23.5%) | 8 (7.2%) | 8 (14.5%) | .162 | 5 (50.0%) | 56 (47.5%) | 38 (50.7%) | .760 |
| Former smoker | 8 (47.1%) | 80 (72.1%) | 36 (65.5%) | 4 (40.0%) | 37 (31.4%) | 26 (34.7%) | ||
| Current smoker | 5 (29.4%) | 23 (20.7%) | 11 (20.0%) | 1 (10.0%) | 25 (21.2%) | 11 (14.7%) | ||
| Glasses alcohol/week | 2 (0–18) | 6 (3–21) | 7 (6–21) | .139 | 0.5 (0–3) | 2 (0–7) | 1 (0.5–6) | .488 |
| Physical performance-related variables at baseline | ||||||||
| Unable to perform tandem stand for 10 s | 4 (23.5%) | 14 (12.6%) | 7 (12.7%) | .468 | 5 (50.0%) | 22 (18.6%) | 23 (30.7%) |
|
| Chair stand, s | 13.0 ± 3.7 | 12.1 ± 3.4 | 11.0 ± 3.1 | .064 | 12.8 ± 2.9 | 12.5 ± 3.9 | 11.8 ± 3.0 | .427 |
| Gait speed, m/s | 0.84 ± 0.26 | 0.92 ± 0.23 | 1.08 ± 0.27 |
| 0.72 ± 0.34 | 0.84 ± 0.20 | 0.95 ± 0.25 |
|
Note: CES-D = Center for Epidemiologic Studies-Depression; LAPAQ = LASA physical activity questionnaire; MMSE = Mini-Mental State Examination.
aMultimorbidity defined as ≥2 of the following chronic diseases: cardiovascular disease, peripheral artery disease, diabetes mellitus, cerebrovascular accident or stroke, chronic obstructive pulmonary disease, arthritis, and cancer.
Data are presented as mean ± SD, n (%), or median (IQR).
*One-way ANOVA for normally distributed variables, Kruskal–Wallis ANOVA for non-normally distributed variables, Chi-square for frequencies.
Comparing the Overlap Between the Different Trajectories for Each Physical Performance Measure
| Comparison | Males | Females | ||||
|---|---|---|---|---|---|---|
| Most Unfavorable Trajectories | Most Favorable Trajectories | Total in Similar Trajectory | Most Unfavorable Trajectories | Most Favorable Trajectories | Total in Similar Trajectory | |
| Chair stand vs gait speed |
|
|
|
|
|
|
| Chair stand vs handgrip strength |
|
|
|
|
|
|
| Gait speed vs handgrip strength |
|
|
|
|
|
|